| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,842 |
10,031 |
$460K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,237 |
2,927 |
$118K |
| 99215 |
Prolong outpt/office vis |
1,443 |
1,305 |
$93K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
1,715 |
1,190 |
$64K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
831 |
498 |
$51K |
| J0897 |
Injection, denosumab, 1 mg |
46 |
38 |
$34K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
248 |
244 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,042 |
1,556 |
$14K |
| 77014 |
|
183 |
40 |
$12K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
14 |
13 |
$12K |
| 96367 |
|
612 |
366 |
$9K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
29 |
26 |
$5K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
21 |
12 |
$3K |
| J1756 |
Injection, iron sucrose, 1 mg |
92 |
59 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
539 |
312 |
$560.88 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
12 |
12 |
$105.74 |